To further understand the mouse immune cell subpopulations associated with anti-tumor response following anti-CD47 treatment, we harvested the tumors on day 15 following the anti-CD47 treatment and analyzed the CD45-positive immune cells by scRNA-seq with 10x Genomics pipeline (Additional file 1: Figure S1A and B). The gene discussed is PTPRC; the disease is neoplasm.